Boundless Bio Sortino Ratio
| BOLD Stock | | | USD 1.51 -0.04 -2.58% |
The Sortino Ratio measures risk-adjusted return using only downside deviation rather than total volatility. Unlike the Sharpe Ratio, which penalizes both upside and downside volatility equally, the Sortino Ratio penalizes only returns below a target threshold, making it a more targeted measure of harmful volatility. Below is Boundless Bio's current Sortino Ratio with peer comparisons and related risk metrics.
Current Sortino Ratio Value
Boundless Bio registers a Sortino Ratio of 0.2433, reflecting its current reading on this measure. This reflects Boundless Bio's positioning relative to its own recent range within Biotechnology.
Sortino Ratio | = | ER[a] - ER[b]DD |
| = | 0.2433 | |
| ER[a] | = | Expected return on investing in Boundless Bio |
| ER[b] | = | Expected return on market index or selected benchmark |
| DD | = | Downside Deviation |
Sortino Ratio Peers Comparison
Boundless Bio falls below the 0.28 peer average for Sortino Ratio. AN2 Therapeutics leads at 0.625 while Plus Therapeutics registers the lowest at 0.0436. Boundless Bio's risk-adjusted return trails the peer average, indicating less efficient compensation for the risk incurred.
Sortino Ratio Relative To Other Indicators
The chart below plots Sortino Ratio against Maximum Drawdown for Boundless Bio and its peers. Each point represents one equity — position along the horizontal axis shows Sortino Ratio while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
With Sortino Ratio at
0.24 and Maximum Drawdown at
35.88 , Boundless Bio shows a
147.48 -to-one ratio between these indicators. This indicates Maximum Drawdown substantially exceeds Sortino Ratio for Boundless Bio.
Methodology, Assumptions & Data Sources
The current Sortino Ratio for Boundless Bio is 0.2433. Boundless Bio's Sortino Ratio is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. Boundless Bio operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The calculation assumes continuous price data across the selected period. All readings are presented as reference data.
Other Technical Indicators